NEOVACS (EPA:ALNEV) | WebDisclosure

Basculer en Français

10429	Companies
218412	Keywords
147916	Articles
115546	Press releases

Home
Companies
NEOVACS

PRESS RELEASE

published on 05/16/2025 at 18:30, 1 year ago

Information relative au nombre total de droits de vote et d'actions composant le capital social
Néovacs communique le nombre d'actions et de droits de vote composant son capital social conformément aux régulations. La société développe des thérapies pour des maladies inflammatoires et auto-immunes

Droits De Vote Capital Social Biopharmaceutique Néovacs Thérapies
BRIEF

published on 05/06/2025 at 20:05, 1 year ago

Capital reduction at Neovacs

Capital Reduction Investor Caution Dilutive Financing Nominal Value Stock Market Pressure
BRIEF

published on 05/06/2025 at 20:05, 1 year ago

Réduction du capital chez Néovacs

Valeur Nominale Réduction Capital Financements Dilutifs Pression Boursière Prudence Investisseur
PRESS RELEASE

published on 05/06/2025 at 20:00, 1 year ago

Ajustement de la valeur nominale
Réduction de capital pour Néovacs, société biopharmaceutique, suite à résolution votée en AG. Focus sur thérapies pour maladies inflammatoires et auto-immunes

Biopharmaceutique Réduction De Capital Maladies Inflammatoires Néovacs Thérapies
BRIEF

published on 05/06/2025 at 08:05, 1 year ago

Neovacs: 2024 Annual Results and Outlook

Financial Results Funding MRNA Vaccine Pharnext Néovacs
BRIEF

published on 05/06/2025 at 08:05, 1 year ago

Néovacs : Résultats annuels 2024 et perspectives

Résultats Financiers Financement Pharnext Néovacs Vaccin ARNm
PRESS RELEASE

published on 05/06/2025 at 08:00, 1 year ago

Résultats annuels 2024
Néovacs annonce des avancées dans le développement de vaccins ARNm contre les allergies, avec une valorisation par un cabinet indépendant. La société présente ses résultats annuels 2024 et son point sur le financement ainsi que le récentrage du portefeuille de participations et de l'investissement dans Pharnext

Financement Résultats Annuels Néovacs Allergies Vaccin ARNm
BRIEF

published on 05/05/2025 at 12:05, 1 year ago

Néovacs réalise une levée de fonds de 1,2 million d'euros

Investissement Biotechnologie Levée De Fonds Dilution OCEANE-BSA
BRIEF

published on 05/05/2025 at 12:05, 1 year ago

Neovacs raises 1.2 million euros in fundraising

Biotechnology Fundraising Investment Dilution OCEANE-BSA
PRESS RELEASE

published on 05/05/2025 at 12:00, 1 year ago

Levée de fonds de 1,2 MEUR
Néovacs annonce une levée de fonds de 1,2 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech

Biotech Levée De Fonds Néovacs Kinoïde® Allergies

Accesswire

Published on 05/20/2026 at 03:21, 3 hours 15 minutes ago

Challenger Assays Extend New Open Pittable Mineralisation
Published on 05/20/2026 at 00:00, 6 hours 36 minutes ago

Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Published on 05/19/2026 at 19:45, 10 hours 51 minutes ago

Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative
Published on 05/19/2026 at 16:47, 13 hours 49 minutes ago

Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order
Published on 05/19/2026 at 15:15, 15 hours 21 minutes ago

Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion

View all ACCESSWIRE

EQS Group

Published on 05/20/2026 at 06:25, 10 minutes ago

Haier Biomedical Publishes 2025 Sustainability Report: Committed to Building a Platform for Technology, Industry and Social Responsibility
Published on 05/19/2026 at 21:24, 9 hours 11 minutes ago

EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards
Published on 05/19/2026 at 19:50, 10 hours 45 minutes ago

EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued
Published on 05/19/2026 at 19:40, 10 hours 55 minutes ago

PRC-Saltillo Named to Forbes Accessibility 200 List
Published on 05/19/2026 at 19:05, 11 hours 30 minutes ago

Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics

Les Echos

Published on 05/19/2026 at 18:45, 11 hours 51 minutes ago

Finalisation de la cession de Novacel
Published on 05/19/2026 at 18:45, 11 hours 51 minutes ago

Closing of the sale of Novacel
Published on 05/19/2026 at 18:34, 12 hours 1 minute ago

Availability of preparatory documents for the annual general meeting to be held on June 9, 2026
Published on 05/19/2026 at 18:34, 12 hours 1 minute ago

Mise à disposition des documents préparatoires à l’assemblée générale annuelle mixte des actionnaires du 9 juin 2026
Published on 05/19/2026 at 18:30, 12 hours 5 minutes ago

TERACT- Communiqué InVivo Group - Retrait obligatoire

View all LES ECHOS COMFI WIRE